Targeting the inflammatory component in atherosclerotic lesions vulnerable to rupture.
D000818:Animals; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D003328:Coronary Thrombosis / Q000000981:diagnostic imaging* / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control; D003331:Coronary Vessels / Q000276:immunology / Q000473:pathology; D004730:Endothelium, Vascular / Q000000981:diagnostic imaging / Q000276:immunology; D006801:Humans; D008264:Macrophages / Q000276:immunology* / Q000473:pathology; D009000:Monocytes / Q000276:immunology* / Q000473:pathology; D011877:Radionuclide Imaging; D012306:Risk